Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University Of Medicine And Dentistry Of New Jersey

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1970-01-01

Employees: -

Market Cap: -

Website: http://www.umdnj.edu/

Clinical Trials

Combination Medications vs. Patch Alone for Medically-Ill Smokers

Phase 4

Completed

Conditions: Smoking Cessation

Interventions: Drug: Nicotine patch
Drug: Nicotine patch, nicotine inhaler, bupropion

First Posted Date: 2008-10-10

Last Posted Date: 2008-10-10

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 127

Registration Number: NCT00770666

Locations: 🇺🇸
Umdnj-Rwjms, New Brunswick, New Jersey, United States

Internet Use Among Women With Recurrent Metastatic Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer

First Posted Date: 2008-10-09

Last Posted Date: 2011-01-31

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 70

Registration Number: NCT00770055

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer

Phase 1

Terminated

Conditions: Breast Cancer

Interventions: Drug: hydroxychloroquine
Drug: ixabepilone

First Posted Date: 2008-10-03

Last Posted Date: 2023-08-09

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 6

Registration Number: NCT00765765

Locations: 🇺🇸
Cancer Institute of New Jersey at Hamilton, Hamilton, New Jersey, United States
🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer

First Posted Date: 2008-09-09

Last Posted Date: 2012-06-14

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 34

Registration Number: NCT00749437

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer

Phase 1

Terminated

Conditions: Lung Cancer

Interventions: Biological: bevacizumab
Drug: carboplatin
Drug: hydroxychloroquine
Drug: paclitaxel

First Posted Date: 2008-08-06

Last Posted Date: 2017-05-23

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 8

Registration Number: NCT00728845

Locations: 🇺🇸
Cancer Institute of New Jersey at Hamilton, Hamilton, New Jersey, United States
🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction

Phase 2

Completed

Conditions: Systemic Sclerosis

Interventions: Drug: Cialis

First Posted Date: 2008-06-30

Last Posted Date: 2008-06-30

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 120

Registration Number: NCT00707187

Locations: 🇺🇸
UMDNJ, New Brunswick, New Jersey, United States

Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma

Phase 3

Completed

Conditions: Systemic Sclerosis

Interventions: Drug: Relaxin

First Posted Date: 2008-06-25

Last Posted Date: 2008-06-25

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 231

Registration Number: NCT00704665

Effects of Sevoflurane and Propofol on Light Flash Evoked Pupillometry

Completed

Conditions: Measurement of Pupil Diameter

First Posted Date: 2008-06-12

Last Posted Date: 2014-12-19

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 30

Registration Number: NCT00695890

Locations: 🇺🇸
UMDNJ, Newark, New Jersey, United States

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Phase 1

Completed

Conditions: Breast Cancer
Colorectal Cancer
Head and Neck Cancer
Lung Cancer
Melanoma (Skin)
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2008-04-28

Last Posted Date: 2011-05-10

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 16

Registration Number: NCT00667641

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Phase 1

Terminated

Conditions: Melanoma (Skin)

First Posted Date: 2008-04-28

Last Posted Date: 2009-12-11

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 15

Registration Number: NCT00667901

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy